![Devin Blass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 340 871 $ am 31.05.2026
Mr. Devin Blass is a Chief Technology Officer & Senior Vice President at Longeveron, Inc. Mr. Blass was previously employed as a Senior Vice President-Comprehensive Cell Solutions by New York Blood Center, Inc., a Vice President-Technical Operations by Talaris Therapeutics, Inc., a Head-Cell Manufacturing Operations by Bellicum Pharmaceuticals, Inc., and a Director-Commercial Program Manufacturing by Mesoblast, Inc. He received his undergraduate degree from Texas State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LONGEVERON INC. CLASS A 1,46 % | 01.05.2026 | 441.543 ( 1,46 % ) | 340 871 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LONGEVERON INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.12.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
New York Blood Center, Inc.
 New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Corporate Officer/Principal | - |
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Corporate Officer/Principal | - |
| TOUE BIOPAR | Geschäftsführer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Health Services |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Texas State University
 Texas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
